TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes (original) (raw)

• Simone, E.A., Wegmann, D.R. & Eisenbarth, G.S. Immunologic “vaccination” for the prevention of autoimmune diabetes (type 1A). Diabetes Care 22 (suppl. 2), B7–B15 (1999).
  PubMed Google Scholar
• Bach, J.F. & Chatenoud, L. Tolerance to islet autoantigens in type 1 diabetes. Annu. Rev. Immunol. 19, 131–161 (2001).
  Article CAS Google Scholar
• Chatenoud, L., Thervet, E., Primo, J. & Bach, J.F. Anti-CD3 antibody induces long-term remission of overt autoimmunity in non obese diabetic mice. Proc. Natl. Acad. Sci. USA 91, 123–127 (1997).
  Article Google Scholar
• Chatenoud, L., Primo, J. & Bach, J.F. CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice. J. Immunol. 158, 2947–2954 (1997).
  CAS PubMed Google Scholar
• Ferran, C. et al. Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation. Eur. J. Immunol. 20, 509–515 (1990).
  Article CAS Google Scholar
• Hirsch, R., Gress, R.E., Pluznik, D.H., Eckhaus, M. & Bluestone, J.A. Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice. II. In vivo activation of T cells. J. Immunol. 142, 737–743 (1989).
  CAS PubMed Google Scholar
• Chatenoud, L., Legendre, C., Ferran, C., Bach, J.F. & Kreis, H. Corticosteroid inhibition of the OKT3-induced cytokine-related syndrome—dosage and kinetics prerequisites. Transplantation 51, 334–338 (1991).
  Article CAS Google Scholar
• Abramowicz, D. et al. Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients. Transplantation 47, 606–608 (1989).
  Article CAS Google Scholar
• Hirsch, R., Bluestone, J.A., de Nenno, L. & Gress, R.E. Anti-CD3 F(ab′)2 fragments are immunosuppressive in vivo without evoking either the strong humoral response or morbidity associated with whole mAb. Transplantation 49, 1117–1123 (1990).
  Article CAS Google Scholar
• Woodle, E.S. et al. Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection. Transplantation 68, 608–616 (1999).
  Article CAS Google Scholar
• Friend, P.J. et al. Phase I study of an engineered aglycosylated humanized CD3 antibody in renal transplant rejection. Transplantation 68, 1632–1637 (1999).
  Article CAS Google Scholar
• Herold, K.C. et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N. Engl. J. Med. 346, 1692–1698 (2002).
  Article CAS Google Scholar
• Chatenoud, L. et al. Human in vivo antigenic modulation induced by the anti-T cell OKT3 monoclonal antibody. Eur. J. Immunol. 12, 979–982 (1982).
  Article CAS Google Scholar
• Hirsch, R., Eckhaus. M., Auchincloss, H.J.R., Sachs, D.H. & Bluestone, J.A. Effects of in vivo administration of anti-T3 monoclonal antibody on T cell function in mice. I. Immunosuppression of transplantation responses. J. Immunol. 140, 3766–3772 (1988).
  CAS PubMed Google Scholar
• Chatenoud, L. & Bach, J.F. Antigenic modulation: a major mechanism of antibody action. Immunol. Today 5, 20–25 (1984).
  Article CAS Google Scholar
• Szanya, V., Ermann, J., Taylor, C., Holness, C. & Fathman, C.G. The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 169, 2461–2465 (2002).
  Article CAS Google Scholar
• Asano, M., Toda, M., Sakaguchi, N. & Sakaguchi, S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184, 387–396 (1996).
  Article CAS Google Scholar
• Takahashi, T. et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192, 303–310 (2000).
  Article CAS Google Scholar
• Itoh, M. et al. Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162, 5317–5327 (1999).
  CAS PubMed Google Scholar
• Suri-Payer, E., Kehn, P.J., Cheever, A.W. & Shevach, E.M. Pathogenesis of post-thymectomy autoimmune gastritis. Identification of anti-H/K adenosine triphosphatase-reactive T cells. J. Immunol. 157, 1799–1808 (1996).
  CAS PubMed Google Scholar
• Stephens, L.A. & Mason, D. CD25 is a marker for CD4(+) thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25(+) and CD25(−) subpopulations. J. Immunol. 165, 3105–3110 (2000).
  Article CAS Google Scholar
• Boitard, C., Yasunami, R., Dardenne, M. & Bach, J.F. T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice. J. Exp. Med. 169, 1669–1680 (1989).
  Article CAS Google Scholar
• Lepault, F., Gagnerault, M.C., Faveeuw, C., Bazin, H & Boitard, C. Lack of L-selectin expression by cells transferring diabetes in NOD mice: insights into the mechanisms involved in diabetes prevention by Mel-14 antibody treatment. Eur. J. Immunol. 25, 1502–1507 (1995).
  Article CAS Google Scholar
• Salomon, B. et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12, 431–440 (2000).
  Article CAS Google Scholar
• Chatenoud, L., Salomon, B. & Bluestone, J.A. Suppressor T cells – they're back and critical for the regulation of autoimmunity. Immunol. Rev. 182, 149–163 (2001).
  Article CAS Google Scholar
• Lenschow, D.J. et al. CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity 5, 285–293 (1996).
  Article CAS Google Scholar
• Nakamura, K., Kitani, A. & Strober. W. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J. Exp. Med. 194, 629–639 (2001).
  Article CAS Google Scholar
• Takahashi, T. et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10, 1969–1979 (1998).
  Article CAS Google Scholar
• Thornton, A.M. & Shevach, E.M. CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188, 287–296 (1998).
  Article CAS Google Scholar
• Piccirillo, C.A. et al. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J. Exp. Med. 196, 237–246 (2002).
  Article CAS Google Scholar
• Wang, B. et al. Interleukin-4 deficiency does not exacerbate disease in NOD mice. Diabetes 47, 1207–1211 (1998).
  Article CAS Google Scholar
• Lucas, C. et al. The autocrine production of transforming growth factor-beta 1 during lymphocyte activation. A study with a monoclonal antibody-based ELISA. J. Immunol. 145, 1415–1425 (1990).
  CAS PubMed Google Scholar
• Bridoux, F. et al. Transforming growth factor beta (TGF-beta)-dependent inhibition of T helper cell 2 (Th2)-induced autoimmunity by self-major histocompatibility complex (MHC) class II-specific, regulatory CD4(+) T cell lines. J. Exp. Med. 185, 1769–1779 (1997).
  Article CAS Google Scholar
• Mallat, Z. et al. Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ. Res. 89, 930–940 (2001).
  Article CAS Google Scholar
• Seddon, B. & Mason, D. Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+)CD45RC(−) cells and CD4(+)CD8(−) thymocytes. J. Exp. Med. 189, 279–289 (1999).
  Article CAS Google Scholar
• Read, S., Malmstrom, V. & Powrie, F. Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med. 192, 295–302 (2000).
  Article CAS Google Scholar
• Chen, W., Jin, W. & Wahl, S.M. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor β (TGF-β) production by murine CD4+ T cells. J. Exp. Med. 188, 1849–1857 (1998).
  Article CAS Google Scholar
• Yasunami, R. & Bach, J.F. Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur. J. Immunol. 18, 481–491 (1988).
  Article CAS Google Scholar
• Powrie, F., Carlino J., Leach M.W., Mauze, S. & Coffman, R.L. A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J. Exp. Med. 183, 2669–2679 (1996).
  Article CAS Google Scholar
• Levings, M.K. et al. Human CD4+CD25+ T suppressor clones profuse transforming growth factor β, but not interleukin 10, and are distinct from type 1 T regulatory cells. J. Exp. Med. 196, 1335–1346 (2002).
  Article CAS Google Scholar
• Ludviksson, B.R., Ehrhardt, R.O. & Strober, W. TGF-β production regulates the development of the 2,4,6-trinitrophenol-conjugated keyhole limpet hemocyanin-induced colonic inflammation in IL-2-deficient mice. J. Immunol. 159, 3622–3628 (1997).
  CAS PubMed Google Scholar
• Papiernik, M., de Moraes, M.L., Pontoux, C., Vasseur, F. & Penit, C. Regulatory CD4 T cells: expression of IL-2R α chain, resistance to clonal deletion and IL-2 dependency. Int. Immunol. 10, 371–378 (1997).
  Article Google Scholar
• Graca, L. et al. Both CD4+CD25+ and CD4+CD25− regulatory cells mediate dominant transplantation tolerance. J. Immunol. 168, 5558–5565 (2002).
  Article CAS Google Scholar
• Luhder, F., Hoglund, P., Allison, J.P., Benoist, C. & Mathis, D. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes. J. Exp. Med. 187, 427–432 (1998).
  Article CAS Google Scholar
• Alegre, M.L. et al. An anti-murine CD3 monoclonal antibody with a low affinity for Fc gamma receptors suppresses transplantation responses while minimizing acute toxicity and immunogenicity. J. Immunol. 155, 1544–1555 (1995).
  CAS PubMed Google Scholar
• Walunas, T.L. et al. CTLA-4 can function as a negative regulator of T cell activation. Immunity 1, 405–413 (1994).
  Article CAS Google Scholar